Impacts of Surgeons’ Experience on Patients with Epiretinal Membrane: A Retrospective Study from 2015 to 2020 in Wenzhou Eye Hospital

Figures & data

Table 1 Baseline Characteristics in the Experienced and Regular Groups

	Experienced Group	Regular Group	P vaule
Number of eyes	211	123
Age (years)	66.3 ± 7.7	65.5 ± 7.9	0.568
Duration of symptoms (months)	21.4 ± 24.4	17.6 ± 19.9	0.100
Female/male	150/61	85/38	0.702
Phakic, n (%)	191 (90.5)	117 (95.1)	0.130
Phacovitrecomy, n (%)	179 (84.8)	108 (87.8)	0.451
ILM peeling, n (%)	167 (79.1)	92 (74.8)	0.358
BCVA (logMAR)	0.48 ± 0.34	0.50 ± 0.33	0.887

Abbreviations: ILM, internal limiting membrane; BCVA, best corrected visual acuity.

Table 2 Distribution of Preoperative BCVA in the Experienced and Regular Groups

	Experienced Group (n = 211)	Regular Group (n = 123)	P value
20/100 or worse, n (%)	67 (31.8)	41 (33.3)	0.766
20/70-20/50, n (%)	64 (30.3)	35 (28.5)	0.717
20/40-20/30, n (%)	41 (19.4)	26 (21.1)	0.707
20/25, n (%)	21 (10.0)	14 (11.4)	0.681
20/20, n (%)	18 (8.5)	7 (5.7)	0.341

Abbreviation: BCVA, best corrected visual acuity.

Figure 1 Preoperative and postoperative BCVA at 1 week, 1 month, 3 months and 6 months in the experienced and regular groups.

Notes: *Indicates a significant difference (p < 0.05) compared to the preoperative baseline; ^†Indicates a significant difference (p < 0.05) compared to the experience group.

Abbreviation: BCVA, best corrected visual acuity.

Figure 2 Preoperative and postoperative BCVA at 1 week, 1 month, 3 months and 6 months in the 20/100 or worse, 20/70-20/50, 20/40-20/30, 20/25 and 20/20 groups.

Figure 3 Change of BCVA in the 20/100 or worse, 20/70-20/50, 20/40-20/30, 20/25 and 20/20 groups at 6 months postoperatively.